Quantum BioPharma Accounts Payable

Quantum BioPharma (QNTM) currently reports a accounts payable of $0 as of June 2026. That compares with $1.9M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Quantum BioPharma's accounts payable history and peer comparisons.

Quantum BioPharma's accounts payable decreased from $1.9M to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Quantum BioPharma reported $0 in accounts payable as of June 2026. That compares with $1.9M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Quantum BioPharma, and consider following QNTM for alerts when major investors trade the stock.